Legal Status of EPT in Kentucky

permissible EPT is permissible.

This is a table caption for compliance. Please ignore it.
I. Statutes/regs on health care providers’ authority to prescribe for STDs to a patient’s partner(s) w/out prior evaluation (Explanation) plus sign “Notwithstanding any other provision of law, a practitioner who is licensed to diagnose and prescribe drugs for a sexually transmitted gonorrhea or chlamydia infection who diagnoses a sexually transmitted gonorrhea or chlamydia infection in a patient may provide expedited partner therapy for a sexually transmitted gonorrhea or chlamydia infection to that patient’s sexual partner or partners.” KRS 214.430 (effective June 27, 2019)
minus symbol Any person infected, or reasonably suspected of being infected, with an STD shall undergo such medical examination as is necessary to determine the existence or nonexistence of diagnosis, and if found to be infected, shall submit to treatment. 902 Ky. Admin. Regs. 2:080.
II. Specific judicial decisions concerning EPT (or like practices) (Explanation)
III. Specific administrative opinions by the Attorney General or medical or pharmacy boards concerning EPT (or like practices) (Explanation) minus symbol …if a nurse or other person is dispensing any sort of prescription drug without the immediate supervision of a pharmacist or physician then they would be in direct violation of the prohibitions against such activity. Ky. Rev. Stat. Ann. §§ 315.020(1)-(2) 1978 Ky. AG LEXIS 286 (OAG 78-450)*
IV. Laws that incorporate via reference guidelines as acceptable practices (including EPT) (Explanation)
V. Prescription requirements (Explanation) plus sign Label not required to have patient name. KRS 217.015 (26); see also KRS 217.065 (2), 217.065 (6), and 217.065 (11)(b).
plus sign Occupations and Professions Code on Pharmacists, which defines “dispense” as delivering a drug “to or use by a patient or other individual entitled to receive the prescription drug.” KRS 315.010
minus symbol Pharmacists must create and maintain patient information, including name address, age, list of all prescriptions from the last 12 months, etc., and give counseling to the patient to optimize drug therapy, as appropriate. 201 KAR 2:210; see also KRS 315.191(1), (5), (6), 42 C.F.R. Part 456*
VI. Assessment of EPT’s legal status with brief comments (Explanation) permissible EPT is permissible.
Statutory authority expressly authorizes EPT for the treatment of chlamydia and gonorrhea.

*This legal authority predates the effective date of the state’s law that authorizes EPT.

Status as of June 27, 2019

Legend

plus sign supports the use of EPT

minus symbol negatively affects the use of EPT

permissible EPT is permissible

potentially allowable EPT is potentially allowable

prohibited EPT is prohibited

This is a table caption for compliance. Ignore it please.
permissible EPT is permissible in 44 states: potentially allowable EPT is potentially allowable in 5 states: prohibited EPT is prohibited in 1 states:
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Mexico
New York
North Carolina
North Dakota
Ohio
Oregon
Pennsylvania
Rhode Island
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
EPT is permissible in the District of Columbia.
Alabama
Kansas
New Jersey
Oklahoma
South Dakota
EPT is potentially allowable in Puerto Rico and Guam.
South Carolina
EPT is prohibited in the Commonwealth of the Northern Mariana Islands.

  

Summary Totals

The information presented here is not legal advice, nor is it a comprehensive analysis of all the legal provisions that could implicate the legality of EPT in a given jurisdiction.  The data and assessment are intended to be used as a tool to assist state and local health departments as they determine locally appropriate ways to control STDs.

For comments, feedback and updates, please contact CDC-INFO: https://www.cdc.gov/cdc-info/.